ATE148165T1 - Stabilisierung von hochgereinigten proteinen - Google Patents

Stabilisierung von hochgereinigten proteinen

Info

Publication number
ATE148165T1
ATE148165T1 AT90113210T AT90113210T ATE148165T1 AT E148165 T1 ATE148165 T1 AT E148165T1 AT 90113210 T AT90113210 T AT 90113210T AT 90113210 T AT90113210 T AT 90113210T AT E148165 T1 ATE148165 T1 AT E148165T1
Authority
AT
Austria
Prior art keywords
protein
stabilization
highly purified
purified proteins
carbohydrate
Prior art date
Application number
AT90113210T
Other languages
English (en)
Inventor
Michael H Coan
Vivian W Lee
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23517903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE148165(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE148165T1 publication Critical patent/ATE148165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90113210T 1989-07-24 1990-07-11 Stabilisierung von hochgereinigten proteinen ATE148165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38458489A 1989-07-24 1989-07-24

Publications (1)

Publication Number Publication Date
ATE148165T1 true ATE148165T1 (de) 1997-02-15

Family

ID=23517903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90113210T ATE148165T1 (de) 1989-07-24 1990-07-11 Stabilisierung von hochgereinigten proteinen

Country Status (8)

Country Link
EP (1) EP0410207B1 (de)
JP (1) JPH0358998A (de)
AT (1) ATE148165T1 (de)
CA (1) CA2021452A1 (de)
DE (1) DE69029765T2 (de)
DK (1) DK0410207T3 (de)
ES (1) ES2097120T3 (de)
GR (1) GR3022614T3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
US6165467A (en) * 1991-07-20 2000-12-26 Yoshihide Hagiwara Stabilized human monoclonal antibody preparation
US6270723B1 (en) * 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
DK1820516T3 (da) 1999-02-22 2013-10-28 Univ Connecticut Nye albuminfrie faktor VIII-præparater
EP1336107B1 (de) 1999-07-14 2009-01-07 Spectral Diagnostics Inc. Präparierung von sphären für diagnostische tests
EP1343518B1 (de) 2000-11-07 2009-07-22 Novartis Vaccines and Diagnostics, Inc. Stabilisierte interferonzusammensetzungen
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
WO2003014339A2 (en) * 2001-08-07 2003-02-20 Novozymes, A/S Carbohydrates and polyols for dissolving protein crystals
KR20030060660A (ko) * 2002-01-10 2003-07-16 손정일 앞/뒷면 구별 없는 양면 양말
CN1703233A (zh) * 2002-07-12 2005-11-30 米德列斯公司 防止蛋白氧化降解的方法和组合物
JP2008501639A (ja) * 2004-04-23 2008-01-24 ノベシン リミテッド タンパク質を安定化、保護及び可溶化させるための方法及びキット
EP1749018B1 (de) * 2004-04-23 2014-10-22 Expedeon Limited Verfahren und kits zur stabilisierung, zum schutz und zur solubilisierung von proteinen
CA2675602A1 (en) * 2007-02-16 2008-08-21 Wyeth Protein formulations containing sorbitol
CN102026621A (zh) 2008-05-15 2011-04-20 巴克斯特国际公司 稳定的药物制剂
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.
EP2646051A4 (de) 2010-12-02 2014-05-28 Oncolytics Biotech Inc Flüssige virale formulierungen
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
AU2012248082B2 (en) * 2011-04-29 2015-08-20 Oncolytics Biotech Inc. Methods of purifying viruses using gel permeation chromatography
CN106687126B (zh) 2014-08-04 2020-07-28 杰特有限公司 因子viii制剂
WO2021001522A1 (en) 2019-07-04 2021-01-07 CSL Behring Lengnau AG A truncated von willebrand factor (vwf) for increasing the in vitro stability of coagulation factor viii
JP2025512143A (ja) 2020-11-09 2025-04-17 武田薬品工業株式会社 酸化ケイ素吸着を使用する血漿からのｆｖｉｉｉの精製

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
JPH0387173A (ja) * 1987-09-10 1991-04-11 Teijin Ltd ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体
CA1329760C (en) * 1987-10-29 1994-05-24 Ted C. K. Lee Plasma and recombinant protein formulations in high ionic strength media

Also Published As

Publication number Publication date
DK0410207T3 (da) 1997-07-14
DE69029765T2 (de) 1997-05-15
GR3022614T3 (en) 1997-05-31
ES2097120T3 (es) 1997-04-01
EP0410207B1 (de) 1997-01-22
EP0410207A2 (de) 1991-01-30
CA2021452A1 (en) 1991-01-25
JPH0358998A (ja) 1991-03-14
DE69029765D1 (de) 1997-03-06
EP0410207A3 (en) 1992-01-15

Similar Documents

Publication Publication Date Title
ATE148165T1 (de) Stabilisierung von hochgereinigten proteinen
DE3874798D1 (de) Therapeutisches proteinagens in form von aerosol.
ATE120960T1 (de) Stabile injizierbare lösungen von faktor viii.
CA2085750A1 (en) Osteoinductive pharmaceutical formulations
DE69230670D1 (de) Zusammensetzungen, die eine blutgerinnselpolymermatrix zur verabreichung von osteogenen proteinen enthalten
WO1989009787A3 (en) Osteogenic devices
DE59510905D1 (de) Hochmolekulare und niedermolekulare Fraktionen des von Willebrand-Faktors
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
DE69219622D1 (de) Herstellung von optisch aktiven aliphatischen carbonsäuren
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
DE69231401D1 (de) Herstellung von faktor-ix
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
ES2058479T3 (es) Compuestos peptidicos.
DE59207095D1 (de) Verfahren zur Herstellung von aktiviertem Protein C
DE69313099D1 (de) Herstellung von optisch aktiven aliphatischen carbonsäuren
ES2104686T3 (es) Uso de una mezcla de peptidos y aminoacidos en la profilaxis o el tratamiento de la demencia.
FI885301A7 (fi) Tekijä VIII:n puhdistuksessa käyttökelpoisia peptidejä
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE101607T1 (de) Aroylharnstoffe.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DE59305709D1 (de) Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-disulfonsäure und 1,4-Diaminoanthrachinon-2,3-dinitril
DK0741746T3 (da) Thymosin alpha 1-analoger
DE59307374D1 (de) Verfahren zur Herstellung von 5-Halogen-2-(1-anthrachinonylamino)benzoesäuren und 4'-Halogen-2,1(N)-anthrachinonyl-1',2'(N)-benzacridonen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification